tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DAWN Stock Latest News

Day One Biopharmaceuticals price target lowered to $24 from $34 at TD Cowen
The FlyDay One Biopharmaceuticals price target lowered to $24 from $34 at TD Cowen
15d ago
DAWN
Day One Biopharmaceuticals: Buy Rating Reiterated as Updated Ojemda Forecasts and DCF Support Attractive Valuation Despite Lowered Price Target
PremiumRatings
Day One Biopharmaceuticals: Buy Rating Reiterated as Updated Ojemda Forecasts and DCF Support Attractive Valuation Despite Lowered Price Target
15d ago
DAWN
Day One Biopharmaceuticals reinstated with a Buy at TD Cowen
PremiumThe Fly
Day One Biopharmaceuticals reinstated with a Buy at TD Cowen
1M ago
DAWN
Day One Biopharmaceuticals: Ojemda Outperformance and Advancing Pipeline Support Overweight Rating
PremiumRatings
Day One Biopharmaceuticals: Ojemda Outperformance and Advancing Pipeline Support Overweight Rating
1M ago
DAWN
Video: Financials weighed down by Trump attacks on Fed, credit card rates
PremiumThe Fly
Video: Financials weighed down by Trump attacks on Fed, credit card rates
1M ago
AXP
COF
Morning Movers: Sun Country jumps after deal to be bought by Allegiant
PremiumThe FlyMorning Movers: Sun Country jumps after deal to be bought by Allegiant
1M ago
C
ANF
Day One Biopharmaceuticals Announces Strong OJEMDA Revenue Outlook
Premium
Company Announcements
Day One Biopharmaceuticals Announces Strong OJEMDA Revenue Outlook
1M ago
8K
DAWN
Day One reports preliminary FY25 Ojemda net product revenue of $155.4M
Premium
The Fly
Day One reports preliminary FY25 Ojemda net product revenue of $155.4M
1M ago
DAWN
Day One Biopharmaceuticals: Ojemda Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
PremiumRatings
Day One Biopharmaceuticals: Ojemda Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
1M ago
DAWN
3 Stocks with a ‘Perfect 10’ Smart Score
PremiumMarket News
3 Stocks with a ‘Perfect 10’ Smart Score
1M ago
DAWN
GLOO
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics
PremiumCompany Announcements
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics
1M ago
8K
DAWN
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics
PremiumThe Fly
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics
1M ago
DAWN
MRSN
Unusually active option classes on open December 18th
PremiumThe FlyUnusually active option classes on open December 18th
2M ago
ACN
CGC
Buy Rating Affirmed for Day One Biopharmaceuticals Based on Promising Long-Term Data from FIREFLY-1 Trial
Premium
Ratings
Buy Rating Affirmed for Day One Biopharmaceuticals Based on Promising Long-Term Data from FIREFLY-1 Trial
3M ago
DAWN
Day One Biopharmaceuticals Reveals Promising Phase 2 Trial Results
Premium
Company Announcements
Day One Biopharmaceuticals Reveals Promising Phase 2 Trial Results
3M ago
8K
DAWN
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising FIREFLY-1 Trial Results and Ojemda’s Market Potential
PremiumRatings
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising FIREFLY-1 Trial Results and Ojemda’s Market Potential
3M ago
DAWN
Promising Clinical Results and Growth Potential Reinforce Buy Rating for Day One Biopharmaceuticals’ Ojemda
PremiumRatings
Promising Clinical Results and Growth Potential Reinforce Buy Rating for Day One Biopharmaceuticals’ Ojemda
3M ago
DAWN
Day One Biopharmaceuticals announces three-year follow-up data from FIREFLY-1
PremiumThe Fly
Day One Biopharmaceuticals announces three-year follow-up data from FIREFLY-1
3M ago
DAWN
Strategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Market Potential: Buy Rating Affirmed
PremiumRatings
Strategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Market Potential: Buy Rating Affirmed
3M ago
DAWN
Strategic Acquisition and Promising Drug Pipeline Drive Buy Rating for Day One Biopharmaceuticals
PremiumRatingsStrategic Acquisition and Promising Drug Pipeline Drive Buy Rating for Day One Biopharmaceuticals
3M ago
DAWN
Strategic Acquisition of Mersana by Day One: Enhancing Pipeline and Growth Prospects
Premium
Ratings
Strategic Acquisition of Mersana by Day One: Enhancing Pipeline and Growth Prospects
3M ago
DAWN
Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
Premium
The Fly
Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
3M ago
DAWN
MRSN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >